Grundinformationen
- Standard-SMILES
CN[C@@H](C)[C@H](O)c1ccccc1.Cl- InChIKey
BALXUFOVQVENIU-GNAZCLTHSA-N- Summenformel
- C10H16ClNO
- Durchschnittliche Molmasse
- 201,69 g/mol
- Monoisotopische Masse
- 201,09204181
Überblick
Ephedrine hydrochloride is an alkylbenzene.
Namen und Bezeichner
- Bevorzugter Name
- Ephedrine Hydrochloride
- IUPAC
- (1R,2S)-2-(methylamino)-1-phenylpropan-1-ol;hydrochloride
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
50-98-6- PubChem CID
- 65326
- DTXSID
DTXSID1045825- ChEMBL
CHEMBL2146102- ChEBI
CHEBI:31541- UNII
- NLJ6390P1Z
- EC Number
- 200-074-6
Eigenschaften
Berechnete Struktureigenschaften
- Polarare Oberfläche (TPSA)
- 32,3 Ų
- H-Brücken-Donoren
- 3
- H-Brücken-Akzeptoren
- 2
- Frei drehbare Bindungen
- 3
- Schwere Atome
- 13
- Formalladung
- 0
- Komplexität
- 121
Experimentelle und physikochemische Eigenschaften
Human Drugs
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 114 reports by companies from 7 notifications to the ECHA C&L Inventory.
Gefahrenhinweise
Regulatory Information
Status: Active Update: 08-11-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/10058
Ephedrine hydrochloride: Does not have an individual approval but may be used under an appropriate group standard
Chemie und Industrie
Pharmakologische Informationen
FDA Pharmacological Classification
EPHEDRINE HYDROCHLORIDE
Increased Norepinephrine Activity [PE]; Norepinephrine Releasing Agent [EPC]; Adrenergic beta-Agonists [MoA]; Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]
MeSH Pharmacological Classification
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.
Drugs used to cause constriction of the blood vessels.
Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.
Verwendung und Herstellung
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…